Crossmark

High On-Treatment Platelet Reactivity as Predictor of Long-term Clinical Outcomes in Stroke Patients with Antiplatelet Agents

Published Online: 2021-10-01

Published Print: 2022-06

Authors

Lv, Huihui

Yang, Zidong

Wu, Haibo

Liu, Mingyuan

Mao, Xiaowei

Liu, Xu

Ding, Hongyan

Shi, Zhuqing

Zhou, Yang

Liu, Qianyun

Zhang, Yongkang

Zhou, Yinting

Chen, Kai

Li, Zezhi

Dong, Qiang

Ma, Jianpeng

Han, Yan https://orcid.org/0000-0002-7654-0906
Funding

Funding for this research was provided by:

National Natural Science Foundation of China (81771288, 81904014)

Shanghai Science and Technology Development Foundation (18401900600)

Shanghai Science and Technology Development Foundation (2018SHZDZX01)
License Information

Text and Data Mining valid from 2021-10-01

Version of Record valid from 2021-10-01
More Information

Article History

Received: 25 November 2020

Revised: 20 August 2021

Accepted: 17 September 2021

First Online: 1 October 2021

Declarations

:

: The authors declare no competing interests.

: All procedures involving human participants were approved by the Ethics Committee of Huashan Hospital (No.2011–260) in accordance with the Helsinki declaration.

: A written informed consent was obtained by all participants before enrolment in the study.

: All the authors have agreed on this publication.

Document is current